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Calcium oxalate nephrolithiasis is a common ailment. Frequent risk factors associated with
it are low diuresis, dietary imbalance, inherited or acquired metabolic disorders. Another
important factor, namely the presence of a mineral deposit made of apatite at the surface
of the papilla, named Randall's plaque (RP), has been recently underlined. In most cases, RP
which serves as a nidus for kidney stone formation is made of calcium phosphate apatite
(CA). However, RP does not seem to be composed exclusively of CA. We would like to
assess the case of RP where sodium hydrogen urate monohydrate (NaUr) is also present in
its chemical composition. To attain this goal, a set of experiments including Environmental
Scanning Electron Microscopy (ESEM) and Synchrotron Radiation Fourier Transform Infra
Red (SR-FTIR) has been performed to analyze papillae of six kidneys randomly selected
after they were surgically removed for cancer. NaUr crystals were found in two samples.
We show through ESEM a usual morphology of RP present at the surface of kidney stones
in the presence of NaUr. Moreover, we discuss the presence of NaUr in the renal paren-
chyma and its spatial repartition with CA. The complete set of data indicates that different
biochemical mechanisms are probably involved in the pathogenesis of RP. The next step
will be to establish a signiﬁcant relationship between these physicochemical data and the
clinical and biochemical data of the patients.
© 2015 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).zin).
ed by Elsevier Masson SAS.1. Introduction
One of the main challenges for urology in the 21st
century is to understand the biochemical mechanisms
involved in the formation of Randall's plaque (RP) [1e4]. RPThis is an open access article under the CC BY-NC-ND license (http://
D. Bazin et al. / C. R. Chimie 19 (2016) 1461e14691462is a white deposit commonly made of calcium phosphate
visible at the tip of papilla beneath the papillary epithe-
lium. It was ﬁrst reported by Alexander Randall in 1936,
and it is considered today as a major factor for nucleation of
calcium oxalate stones. From an epidemiologic point of
view, a progression in the presence of RP at the tip of the
papilla has been recently reported in industrialized coun-
tries [5e7]. More precisely, in US up to 80% of calcium stone
formers present Randall's plaque at the tip of their papillae
[8]. In France, more than 50% of stone formers exhibit
Randall's plaque [9]. Stone formation is proportional to
papillary surface coverage by RP, which may explain the
signiﬁcant increase of kidney stone prevalence observed
over the past two decades in industrialized countries
[10e14].
In the recent model proposed by A.P. Evan et al. [15,16],
apatite plaque begins in the basement membrane of the
thin loops of Henle, and spreads from there into the
papillary interstitium. The starting point of our investiga-
tion is given by the observation that, if calcium phosphate
apatite (CA) is the major component of most RP, other
chemical phases can be found, such as amorphous
carbonated calcium phosphate (ACCP) [17], whitlockite
(WK), brushite, uric acid and sodium hydrogen urate
monohydrate (NaUr) [18]. Even if NaUr is present in only
3.5% of RP [19], it represents a high number of patients,
about 70000 subjects in France. Indeed, the occurrence of
NaUr in urinary calculi is around 0.7%, i.e. 5 times less than
in RP. Such chemical diversity of RP could indicate that RP
begins not only in the basement membrane of the thin
loops of Henle but in other parts of the kidney.
The aim of this study which follows our previous ones
dedicated to RP [5,17,20,21] is to seek and discuss the
presence of NaUr crystals in RP at the surface of kidney
stones as well as in kidney tissues. Investigation regarding
such pathological calciﬁcations [22e25] calls for a set of in-
lab techniques [26e39] or ones related to large scale in-
struments [40e49] capable of multi scale description
[50,51]. Observations of the topology at the micrometer
scale of RP present at the surface of calculi have been per-
formed through an Environmental Scanning Electron Mi-
croscopy (ESEM) equipped with an energy-dispersive X-ray
spectrometer (EDS) [52e54]. The chemical composition of
such biological entities was obtained through classical
Fourier Transform Infrared (FT-IR) spectroscopy [55].
Moreover, in order to obtain the spatial distribution of NaUr
in kidney tissue slices, Synchrotron Radiation mFT-IR (SR-
FTIR) data have been also collected [56e61].
2. Materials and methods
The biological samples including kidney tissue slices
and kidney stones used in the present investigation came
from Tenon hospital. As a referal center for stone analysis,
the urolithiasis laboratory of AP-HP has had the opportu-
nity to perform a morphoconstitutional analysis of more
than 70,000 urinary stones over the past three decades
coming from more than ﬁfty hospitals in France. Such an
analytical procedure based on the structure and the
chemistry is of primary importance [62e64] and was pre-
viously described [65,66]. Because a number of stones arenow removed from the urinary tract by various fragmen-
tation techniques including ESWL, percutaneous neph-
rolithotomy or ureteroscopy, we selected only
unfragmented stones, i.e. a cohort of 35,323 calculi.
Regarding ectopic calciﬁcations, healthy parts of six
kidneys removed by nephrectomy for cancer were used for
seeking the presence of crystal deposits in the papillae.
All specimens were snap frozen and ﬁxed with acetone.
For light microscopy analysis, sections were stained with
hematoxyline. For ESEM and SR-mFTIR analysis, four micron
slices of the papillae’s tip were deposited on low-e micro-
scope slides (MirrIR, Kevley Technologies, Tienta Sciences,
Indianapolis). Consent was obtained from Tenon hospital
urology team according to the French legislation and
samples were immediately anonymized. No data about
patients were collected.
An FEI/Philips XL40 Environmental Scanning Electron
Microscopy (ESEM) equipped with an energy-dispersive X-
ray spectrometer (EDS) was used for a precise description
of the sample topology [22e25]. An important feature of
the ESEM compared to a conventional SEM is the fact that
non-conductive materials can be imaged without any
conductive coating, which permits a direct observation
with no damage to the sample. Imaging was performed
with a gaseous secondary electron detector, an accelerating
voltage of 20 kV and a water pressure of 0.4 torr in the
chamber. This low pressure was used to maintain a high
spatial resolution for the X-ray analysis by minimizing the
scattering of the primary electron beam. Also, a Zeiss
SUPRA55-VP type scanning electron microscope was used
for microstructure observation. This ﬁeld effect gun mi-
croscope operates at 0.5e30 kV. High resolution observa-
tions were obtained using two secondary electron
detectors: an in lens SE detector and an Everhart-Thornley
SE detector.
SR-mFTIR experiments were performed at the infrared
beamline SMIS of the Soleil-Synchrotron (St Aubin-Gif sur
Yvette) operating in top-up mode at 300 mA [67]. The IR
spectra were collected in reﬂection mode using an infrared
microscope (Continuum-Thermo Electron Corporation)
coupled to an FTIR spectrometer (Thermo Nicolet Nicplan
IR microscope 32X/NA0.6 objective). The IR microscope is
equipped with a motorized sample stage (precision 0.5 mm)
and a liquid nitrogen cooled mercury cadmium telluride
(MCT) detector (50 mm size). Each spectrum was acquired
after 100 accumulations (1 mn) at 4 cm1 spectral resolu-
tion in the range of 650e4000 cm1. The spatial resolution
was 11  11 mm2. Data acquisition and processing were




From an epidemiologic point of view, among 35,323
unfragmented calculi referred to our stone laboratory over
the past three decades, morphologic examination coupled
with FTIR identiﬁed 10,462 (29.6%) umbilicated calculi
initiated from a papillary deposit, namely a RP. Most of
these stones (89.5%) were made of calcium oxalate
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oxalate dihydrate. Regarding the chemical composition of
RP, we have already pointed out its chemical diversity
[5,17,19e21]. Among 10,462 RP analyses, we found CA in
95.6%, ACCP in 7.2%, NaUr in 3.4%, and WK in 1% of cases.
Other compounds were also identiﬁed such as brushite,
bobierrite, opale, uric acid and some rare urates, overall
representing less than 0.35% of cases. Of note, 16.9% of RP
found in the stones appeared as mixtures of two or more
crystalline phases irrespective of calcium oxalate. Of note,
even if NaUr is present in 3.4% of the RP, it corresponds to a
large number of patients. In 28% of cases, NaUr was the only
crystalline phase identiﬁed in RP. In the other cases, it was
mixed with either CA or ACCP. The presence of NaUr in RP
appeared to be sex dependent since NaUr-containing RP
was found in 4.3% of stones from male patients and in only
0.6% of cases in female patients (p < 0.00001).3.2. Description of RP on kidney stones at the micrometer
scale through ESEM and FTIR
The different RP containing NaUr displays a quite similar
structure at the micrometer scale (Fig. 1a). On the ESEM
photograph of a typical RP containing NaUr (Fig. 1b), a core
(Area 1 in Fig. 1b) surrounded by needles (Area 2 in Fig. 1b)
is observed. Such structural description is completed by
FTIR spectroscopy in order to identify its chemical
composition. The IR absorption band at 1037 cm1 in-
dicates that the core (Area 1 on Fig. 1b) is made of CA
(Fig. 2a), while the needles (Area 2 on Fig.1b) are composed
of NaUr (its speciﬁc bands are positioned at 3600 and
1004 cm1 on Fig. 2b). As shown in Fig. 2c, the stone layers
surrounding RP (Area 3 in Fig. 1b) are made of whewellite.
At higher magniﬁcation, we can see through ESEM that
the central part in Fig. 1b (area 1) is made of an intimateFig. 1. (a) Microscopic aspect of an RP made of a mixing of NaUr needles and carb
whewellite (area 3). NaUr needles of large dimension are visible on area 2.mixing of CA spherules [68e72] and NaUr acicular entities
with the presence of small spherical entities at the ex-
tremity of the needles (Fig. 3a). Complementary informa-
tion is given by EDS measurements regarding the
elementary composition of these spherical and needle en-
tities (Fig. 3b). EDS spectra indicate that spherical entities
are made of Ca, P and O while needles are made of Na, C, O
and N.3.3. Shedding light on the presence of NaUr in kidney tissue
Regarding kidney tissue, we perform this investigation
through polarizing microscopy, ESEM at the mesoscopic
scale and SR-mFTIR analysis on the same samples. Six
randomly selected kidneys were examined.
Among the papillae analyzed by SR-mFTIR, several from
three different kidneys (50%) presentedwith incipient RP at
the tip of the papillae. Polarized light microscopic exami-
nation of tissues revealed two types of tissular crystal ag-
gregates in two of the six kidneys: unorganized and
unpolarizing aggregates, closely associated with needle-
shaped polarizing crystals (Fig. 4) while in one third kid-
ney, only unorganized non-polarized aggregates were
found. SR-mFTIR analysis of these incipient plaques
revealed a mixed composition of NaUr (needle-shaped
polarizing crystals) and CA (large non-polarized aggre-
gates, Fig. 5a).
S.R.-mFTIR analysis proved that needles were made of
NaUr and spherules were made of CA. In some parts of the
deposits, the two chemical species were mixed as shown in
Fig. 5a. While CA deposit resembles a plug within a renal
tubule, needle-shaped crystals of NaUr seem to be located
both in the tubule and in the interstitium (Fig. 4). In addi-
tion, in another part of the same kidney sample, deposits
within the papilla were located around the tubule. Infraredapatite (black arrow) (b) RP (areas 1 and 2) attached on a calculus made of
Fig. 2. Infrared spectra of different parts of RP and of the ﬁrst layers of the stone around RP: (a) calcium phosphate apatite (b) NaUr (c) whewellite.
Fig. 3. (a) At the extremity of some NaUr needles, white spherical entities are visible (b) Elementary composition through EDS of the white spherical entities
show that these entities are made of Ca, P and O.
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form of calcium phosphate containingMg ions. Whitlockite
was mixed with CA (Fig. 5b). NaUr crystal aggregates were
sometimes surrounded by numerous cells as observed in
Fig. 6, thus suggesting an inﬂammatory process not
observed in other parts of the tissue where only CA or
CA þ WK mixture was found. ESEM photographs also
conﬁrm the close association between NaUr needles and CA
spherules (Fig. 7).4. Discussion
From a medical point of view, ectopic calciﬁcation
deﬁned as inappropriate biomineralization occurring in
soft tissue (which can be related to severe pathologies like
breast or testicular cancer) and concretion deﬁned as the
deposition of crystalline materials in excretory ducts (KS,
also gallstones, salivary stones and so on.) constitute two
very different families of pathological calciﬁcations [22].
Fig. 4. Crystal deposit observed by polarizing microscopy within the papilla
of a kidney. Two types of crystals may be observed: CA (black arrow) and
NaUr (white arrow).
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concretion on an ectopic calciﬁcation.
The fact that several epidemiologic studies point out
Randall's plaque as a major public health problem have
induced a number of investigations in order to understand
precisely the biomechanims responsible for the formation
of these ectopic calciﬁcations [73e101]. Recently, S.R. Khan
et al. have reported that RP starts as small, discrete spher-
ical entities, perhaps as a result of mineral imbalance, but it
grows by the addition of more crystals through the
mineralization of membranous vesicles and collagen ﬁbers
[102]. Other authors have considered genetically engi-
neered mice lacking TammeHorsfall protein as a possible
animal model of Randall's plaque [103]. Their data show
that the location, ultra-structure, chemical composition
and lack of associated inﬂammation of the interstitial
crystals in THP-null mice strongly resemble those of RP
found in humans. Other authors advance the hypothesis
that RP constitutes a truly ectopic biomineralization in the
renal tissue, and that Henle's loop epithelial cells, or
pericyte-like interstitial cells, or papillary stem cells
differentiating along a bone lineage might be involved
[104].
All these studies discuss only CA RP. The starting point of
our investigation was based on the observation that
different chemical phases have been identiﬁed in RP
opening a discussion of the initial model in which only CA
based RP have been identiﬁed [15,16]. First, observations at
the micrometer scale through ESEM on a typical RP con-
taining NaUr show clearly that large needles of NaUr are
present around a central part made of an intimatemixing of
CA spherules and NaUr needles. Such spatial description is
far from the onewe have observed previously for apatite RP
[8,15,16]. As previously reported, it seems that apatite RP is
the result of an agglomeration of empty and apatite ﬁlled
cylindric channels which correspond both to calciﬁed Bel-
lini’s ducts and vessels and to collecting ducts ﬁlled by CA
plugs [8,15,16]. Thus RP at the surface of the papillaepithelium could be the consequence of an agglomeration
of CA spherules from both interstitium and tubular lumen
as suggested by the very highly variable carbonation rate of
CA [5]. These ESEM observations indicate clearly that
different biochemical mechanisms are involved in the
pathogenesis of RP. The simultaneous presence of CA and
NaUr in 3.4% of RP suggests the involvement of urate salt in
a number of patients, i.e. more than 70,000 subjects in
France based on epidemiological data regarding the prev-
alence of kidney stones in the general population. More-
over, among the six kidney tissue samples analyzed for
identifying possible ectopic crystals, we found NaUr in two
cases, i.e. one third of the kidneys, which is a very high
occurrence.
To address more deeply the presence of NaUr in RP, SR-
FTIR spectroscopy, a technique which combines IR spec-
troscopy and microscopy for determining the distribution
of molecular groups at the cell scale has been used
[71,105e114]. Thanks to 2D imaging and the high signal to
noise ratio, different publications have shown that such an
approach is particularly suitable for tissues which are
usually complex and heterogeneous [105e118]. Regarding
the different kidney slices that we have considered in this
investigation, SR-mFTIR experiments point out the presence
of NaUr in the renal papilla as well as an intimate mixing of
CA and NaUr. From a physicochemical point of view, NaUr
and apatite may have epitaxial relationships. In 1976, Pak
reported that NaUr was able to serve as a heterogeneous
nucleator for hydroxyapatite and conversely [119].
Several studies have considered the relationship
between NaUr and calcium oxalate stones. Some authors
underline that particulate monosodium urate is likely
to inﬂuence calcium oxalate stone formation by binding
to and attenuating the potency of urinary inhibitors
[120].
However, our results highlight that NaUr may also
segregate with CA at the tip of renal papillae. Our data
deserve further studies to identify whether urate crystals
originate from tubular structures or grow within inter-
stitium. The close association of urate and apatite in tissues,
as well as in established plaques, is striking: these two
crystalline phases usually do not coexist in renal stones.
Moreover, the identiﬁcation of urate in at least some
incipient Randall's plaques may impact surrounding tis-
sues. Actually, NaUr crystals have been identiﬁed a few
years ago as a powerful danger signal, triggering NLRP3
inﬂammasome-dependent and independent pathways to
generate interleukin-1 beta synthesis and innate immune
cell recruitment [121]. Our observation of cells around
NaUr crystal aggregates may advocate this pro-
inﬂammatory role. This observation may be a clue to un-
derstand the discrepancy in the literature about the po-
tential link between Randall's plaque and inﬂammation
[122,123]. One may hypothesize that the inconstant pres-
ence of urate salts within plaque is the trigger of inﬂam-
matory cell recruitment. Our data are too sparse to draw
any deﬁnitive conclusion on this topic but we did not
identify any immune cell inﬁltrate surrounding the CA
incipient Randall's plaque devoid of urate salts. Work is in
progress to identify the cells observed around NaUr
crystals.
Fig. 5. Infrared spectra of two different parts of the crystal deposits found in the papilla of the same kidney (a) spectrum of CA mixed with NaUr (b) spectrum of
whitlockite mixed with CA.
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Fig. 6. Magniﬁcation of the crystal deposit seen in Fig. 4. Note the presence
of numerous cells (arrows) around the needle-shaped crystals made of NaUr
monohydrate.
Fig. 7. Observations through ESEM of a kidney slice show the presence of
both NaUr needles and apatite spherical entities.
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The complete set of data shows that Randall's plaques
are not always made of apatite, but may also contain other
phosphate salts and oxypurines such as NaUr that modify
signiﬁcantly their morphology at the micrometer scale.
Such a ﬁnding suggests that several pathways are involved
in the RP formation. The latter phase is present in kidney
tissue quite close to apatite, an experimental fact which has
not been included in the biochemical mechanisms involved
in the pathogenesis of Randall's plaque. As Coe et al. said,
“No single theory of pathogenesis can properly account for
all human kidney stones.” It seems that this sentence is alsotrue for Randall's plaque [123]. Further investigations are
needed to establish a signiﬁcant relationship between such
chemical and structural data and the clinical data of the
patients.
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